BG Reddit Mentions | ChartExchange

Building on what others said about thin margins, I think the ADM-vs-BG framing might be the wrong question. Both are price-takers on a crush spread, so neither really has the pricing power that makes something compound. Picking between them isn't picking the better compounder, it's picking which risk you'd rather hold.
With ADM you're holding the accounting question someone flagged above. The nutrition segment was supposed to be the margin hedge, and it's the exact part that drew the SEC inquiry, so your reason to prefer ADM and your biggest risk in ADM are the same segment. With BG you're holding execution and leverage risk on Viterra, which is at least a cleaner, more trackable risk: Net Debt/EBITDA either comes down on schedule or it doesn't, and you'll see it quarter by quarter.
So I'd reframe it. If you want a defensive sleeve, an unresolved accounting overhang isn't defensive no matter how steady the dividend looks. If you're underwriting the Viterra deleveraging and you think the optionality is real, BG is a definable bet with a number you can watch. But "diversify into food" as a goal worries me a bit. These are commodity processors, not consumer-staples compounders. The dividend longevity is real, but a 50-year payout funded by a low-margin, cyclical, capital-hungry business is a different animal than the staples people usually mean when they say defensive.

document.getElementById("F7GkFp").onerror = function(){this.style.display='none';}; .dark-mode .WqpByy{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .WqpByy{ color: #333333; background-color: white; border: 2px solid #333333; }BGBunge Global SAstock NYSE

BG
Bunge Global SA
stock NYSE